Trinity Biotech (TRIB) Capital Leases (2016 - 2025)
Trinity Biotech's Capital Leases history spans 10 years, with the latest figure at $10.8 million for Q4 2025.
- On a quarterly basis, Capital Leases rose 3.46% to $10.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.8 million, a 3.46% increase, with the full-year FY2025 number at $10.8 million, up 3.46% from a year prior.
- Capital Leases hit $10.8 million in Q4 2025 for Trinity Biotech, up from $10.5 million in the prior quarter.
- Over the last five years, Capital Leases for TRIB hit a ceiling of $13.9 million in Q4 2021 and a floor of $10.5 million in Q4 2024.
- Historically, Capital Leases has averaged $11.7 million across 5 years, with a median of $10.9 million in 2023.
- Biggest five-year swings in Capital Leases: dropped 16.42% in 2021 and later increased 3.46% in 2025.
- Tracing TRIB's Capital Leases over 5 years: stood at $13.9 million in 2021, then fell by 11.53% to $12.3 million in 2022, then fell by 11.37% to $10.9 million in 2023, then dropped by 3.63% to $10.5 million in 2024, then increased by 3.46% to $10.8 million in 2025.
- Business Quant data shows Capital Leases for TRIB at $10.8 million in Q4 2025, $10.5 million in Q4 2024, and $10.9 million in Q4 2023.